APA (7th ed.) Citation

Stahl, A., Bründer, M., Lagrèze, W. A., Molnár, F. E., Barth, T., Eter, N., . . . Hentschel, R. (2022). Ranibizumab in retinopathy of prematurity – one‐year follow‐up of ophthalmic outcomes and two‐year follow‐up of neurodevelopmental outcomes from the CARE‐ROP study. Acta Ophthalmologica (1755375X), 100(1), e91. https://doi.org/10.1111/aos.14852

Chicago Style (17th ed.) Citation

Stahl, Andreas, et al. "Ranibizumab in Retinopathy of Prematurity – One‐year Follow‐up of Ophthalmic Outcomes and Two‐year Follow‐up of Neurodevelopmental Outcomes from the CARE‐ROP Study." Acta Ophthalmologica (1755375X) 100, no. 1 (2022): e91. https://doi.org/10.1111/aos.14852.

MLA (9th ed.) Citation

Stahl, Andreas, et al. "Ranibizumab in Retinopathy of Prematurity – One‐year Follow‐up of Ophthalmic Outcomes and Two‐year Follow‐up of Neurodevelopmental Outcomes from the CARE‐ROP Study." Acta Ophthalmologica (1755375X), vol. 100, no. 1, 2022, p. e91, https://doi.org/10.1111/aos.14852.